KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health officials in the Democratic Republic of the Congo have launched a targeted Ebola immunization effort in Kisangani,the administrative center of Tshopo Province, aiming to stem the deadliest outbreak of the disease ever recorded in the country. Priority during the initial rollout is given to frontline healthcare providers, emergency responders, and those with direct contact with confirmed cases. Health Minister Roger Kamba confirmed that the government has started the vaccination campaign using doses of the Ervebo vaccine to protect front-line workers operating in the affected eastern provinces.
Official epidemiological reports show that the outbreak has now spread to six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Data published by the Ministry of Public Health and Prevention reveal that there have been 5,713 confirmed cases and 2,744 deaths so far. The current case fatality rate among confirmed patients is approximately 48%.
International health organizations, including the World Health Organization, have stepped in to support local teams with logistics, laboratory testing, and vaccine distribution efforts. Authorities are deploying the Ervebo vaccine under a compassionate-use program while researchers gather observational data on its effectiveness against the circulating viral strain in the region. DR Congo has launched an Ebola vaccination campaign as health teams escalate ring-vaccination around infection clusters to cut off transmission pathways.
DR Congo Rolls Out Ebola Vaccination Across Affected Eastern Provinces
Operational challenges persist due to regional infrastructure issues, ongoing security issues, and high population movement across border areas. Kisangani has established cold-chain logistics to keep vaccines at ultra-low temperatures before they are transported to remote health zones. The country is executing the Ebola vaccination effort while civil defense and community health workers conduct outreach programs to boost disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention collaborate with local teams to monitor adverse reactions and assess immune responses among vaccinated populations. Officials emphasize that early detection, combined with isolation procedures and supportive treatments, remains key to improving patient survival chances. Additional vaccine shipments are planned to support expanding regional distribution efforts across secondary health districts.
Kisangani Acts as the Central Hub for Regional Vaccine Deployment
National response teams continue to expand contact tracing in urban and rural areas of the eastern region. Local health centers are supplied with personal protective equipment, diagnostic reagents, and treatment supplies to bolster preparedness. The government has reaffirmed that comprehensive public health measures will stay in place until viral transmission decreases consistently across all affected provinces.
Authorities urge communities to fully cooperate with mobile vaccination teams and follow established health guidelines. Experts believe that increasing immunization among high-risk populations will help stabilize infection rates in the coming weeks. Surveillance networks will maintain heightened monitoring at transportation hubs and border crossings to prevent further spread.